BioPharmX Corporation is on the Cruelty Free Investing use of animals list because they use animals for conducting pre-clinical studies of their drugs.
The following report cites that, “The company is currently conducting an animal toxicity study, after which they expect to submit it to the FDA to initiate their first Phase 2a clinical trial of BPX01. (page 5)”. Link to the full report
The findings showed that BPX-01’s unique formulation of minocycline may represent a breakthrough in acne treatment because it can safely deliver the antibiotic to the layer of skin where acne develops as experimented in animal models and in vitro human skin.
BioPharmX Corp. engages in providing healthcare products through platform technologies for pharmaceutical, over-the-counter and supplement applications in dermatology. The company was founded by James R. Pekarsky on August 30, 2010 and is headquartered in Menlo Park, CA. [Source: MarketWatch]